Kynexis (private company)
See something wrong or missing? Let us know
Offices:Amsterdam
Industry:BiotechHealth servicesPharma
Business model:B2B
Kynexis is a Ducth biotech startup advancing the first potential precision medicine for the treatment of cognitive impairment associated with schizophrenia (CIAS).
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 60.42M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Kynexis
Name | Criteria | |
---|---|---|
![]() |
AbolerIS Pharma
67%
|
|
![]() |
Acesion Pharma
67%
|
|
![]() |
Cinclus Pharma
67%
|
|
![]() |
NMD Pharma
67%
|
|
![]() |
ReViral
67%
|
|
![]() |
Sanifit Therapeutics
67%
|
|
![]() |
STipe Therapeutics
67%
|
|
![]() |
Synklino
67%
|
|
![]() |
Theolytics
67%
|
|
![]() |
Cytoki Pharma
67%
|
|